ON-DEMAND webinar: Advanced prostate cancer – how do we move forward in patient management?

Learning objectives:         

After attending this symposium, participants should be able to:

• Review the current management strategies for metastatic hormone-sensitive prostate cancer (mHSPC) to optimise patient care
• Discuss the impact of new data on treatment and management decisions forindividual patients with non-metastatic castration-resistant prostate cancer(nmCRPC) and metastatic castration-resistant prostate cancer (mCRPC)
• Describe considerations for managing patients with prostate cancer duringthe COVID-19 pandemic

Scientific Committee:

• Eleni Efstathiou (USA)
• Boris Hadaschik (Germany) 

Faculty:

• Elena Castro (Spain)
• Kim Chi (Canada) 
• Nicolas Mottet (France)